Flow Cytometry Market, By End-user (Hospitals, Medical schools and clinical testing labs, Commercial organizations, Academic institutions, and Others), By Technology (Cell-based flow cytometry, and Bead-based flow cytometry), By Component (Instruments, Reagents, and consumables, Software, and Services), By Application (Academic and clinical applications, and Diagnostic applications), By Region Analysis - Global Analysis And Industry Forecast Report Till 2030.

The Flow Cytometry Market is projected to grow from $4.253 billion to $7.91 billion, at a CAGR of 7.14% during the forecast period 2021-2030.

Flow cytometry is a widely used method to analyze the expression of cell surface and intracellular molecules, and characterize and define different cell types in heterogeneous cell populations. It analyzes cell size and volume, and examines the purity of isolated subpopulations. Simultaneous multi-parameter analysis of single cells is possible. It is applied to measure the fluorescence intensity generated by fluorescently labeled antibodies that detect proteins and ligands that bind to specific cell-associated molecules, such as propidium iodide that binds to DNA.

This process involves a staining procedure, followed by incubation of cells in tubes or microtiter plates with unlabeled or fluorochrome-labeled antibodies, and finally analysis on a flow cytometer. The flow cytometry market size is boosted by technological advancements and high adoption rate in various research and diagnostic applications. Additionally, the emergence of flow cytometry technology in new research applications such as cytogenomics, proteomics, and marine biology further complements the market share.

Flow cytometry analysis is a powerful technique used in cytometry research to investigate various cellular characteristics. By employing instruments such as BD SpectrumViewer and Cytek Aurora, scientists can analyze and sort cells based on their unique properties. FACS flow cytometry enables precise identification and isolation of specific cell populations through the process of cell sorting. This comprehensive approach to cytometry analysis provides valuable insights into cellular function, allowing researchers to explore and understand complex biological processes at a molecular level.

Market Dynamics:

Drivers:

Rapid advancements in technological aspects, increasing incidence of chronic diseases requiring validation, and the need for precise and sophisticated techniques for disease validation are some of the major drivers for the flow cytometry market. Researchers are using flow cytometry to qualitatively and quantitatively analyze peripheral blood cells to predict immunotherapy outcomes in large quantities. The flow cytometry market is primarily driven by the expansion of high-resolution, improved efficiency, and efficient statistical platforms.

Restraints:

Factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and inadequate availability of technical expertise are expected to hamper the growth of the flow cytometry market.

Opportunities:

In terms of opportunities, the market has observed significant growth in the biotechnology sector and applications in various fields such as drug discovery, cell culture, and stem cell therapy. In addition, the surge in demand for fast and accurate cancer prognostic tools coupled with the surging spread of infectious diseases is expected to propel market growth and create opportunities.

Key Players:

• Beckman Coulter Inc

• Becton Dickinson and Company

• Danaher

• Thermo Fisher Scientific

• Merck KGA

• Bio-Rad Laboratories Inc.

• Luminex Corporation

• Miltenyi Biotec

• Sysmex Partec GmbH

• Agilent Technologies Inc.

• Stratedigm, Inc.

• Apogee Flow Systems Ltd.

• Sony Biotechnology, Inc.

• Thermo Fisher Scientific, Inc.

Market Segmentation:

Flow Cytometry Market, By Component

• Instruments

• Reagents and consumables

• Software

• Services

Flow Cytometry Market, By Technology

• Cell based flow cytometry

• Bead based flow cytometry

Flow Cytometry Market, By End-user

• Hospitals

• Medical schools and clinical testing labs

• Commercial organizations

• Academic institutions

• Others

Flow Cytometry Market, By Application

• Academic and clinical applications

• Diagnostic applications

Flow Cytometry Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

North America dominated the overall market with the largest share in 2022. This advantage is due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the United States. The presence of research universities and established pharmaceutical companies has created a tremendous demand for flow cytometry workflows for research needs.

The Asia Pacific region is expected to witness a significant CAGR of XX% during the forecast period. It is expected to be the fastest-growing region in this market. This is due to the growth of pharmaceutical and biotech industries in emerging economies such as China and India. The industry is driven by the increasing incidence of chronic diseases and the increasing use of cellular analysis devices in various applications in the region. Additionally, extensive research activities by regional players for the improvement or development of innovative flow cytometry solutions are expected to support the market growth in the region over the projected period.

Scope of the report:

User

Tab Content